bpc-157 human clinical trial evidence safety regulatory status trials review BPC- 157 (20mg) – Telomere Research Peptide bpc-157 human clinical trials evidence

In this work, we focused on the prototype cytoprotective anti-ulcer peptide stable gastric pentadecapeptide BPC 157, which has been used in trials for ulcerative colitis and now for multiple sclerosis, in the treatment of colitis and ischemia in rats[2-8], seeking new insights into ischemic colitis (IC), ischemia and reperfusion and therapy

#1 Methylfolate (5-MTHF / L-Methylfolate) This is the centerpiece

What it does not yet have is a controlled human trial

Cancer Res Treat

The most common response that we get from our patients is was that it? or that was the easiest injection that I have ever gotten

BPC-157 Pure oral spray The oral spray represents a different delivery strategy